Your browser doesn't support javascript.
loading
Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
Smith, Todd; Muller, David C; Moons, Karel G M; Cross, Amanda J; Johansson, Mattias; Ferrari, Pietro; Fagherazzi, Guy; Peeters, Petra H M; Severi, Gianluca; Hüsing, Anika; Kaaks, Rudolf; Tjonneland, Anne; Olsen, Anja; Overvad, Kim; Bonet, Catalina; Rodriguez-Barranco, Miguel; Huerta, Jose Maria; Barricarte Gurrea, Aurelio; Bradbury, Kathryn E; Trichopoulou, Antonia; Bamia, Christina; Orfanos, Philippos; Palli, Domenico; Pala, Valeria; Vineis, Paolo; Bueno-de-Mesquita, Bas; Ohlsson, Bodil; Harlid, Sophia; Van Guelpen, Bethany; Skeie, Guri; Weiderpass, Elisabete; Jenab, Mazda; Murphy, Neil; Riboli, Elio; Gunter, Marc J; Aleksandrova, Krasimira Jekova; Tzoulaki, Ioanna.
Afiliação
  • Smith T; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Muller DC; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Moons KGM; Julius Center for Health Sciences and Primary Care, Umc Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Cross AJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Johansson M; International Agency for Research on Cancer (IARC), Genetic Epidemiology Group, Lyon, France.
  • Ferrari P; Nutritional Methodology and Biostatistics Group (NMB), International Agency for Research on Cancer, Lyon, France.
  • Fagherazzi G; Inserm U1018, Gustave Roussy, Universite Paris-Sud, Villejuif, France.
  • Peeters PHM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Severi G; Inserm U1018, Gustave Roussy, Universite Paris-Sud, Villejuif, France.
  • Hüsing A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tjonneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Olsen A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Overvad K; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
  • Bonet C; Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Barcelona, Spain.
  • Rodriguez-Barranco M; CIBER de Epidemiologia y Salud Publica (CIBERESP), Escuela Andaluza de Salud Publica, Madrid, Spain.
  • Huerta JM; Murcia Regional Health Council, IMIB-Arrixaca, CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.
  • Barricarte Gurrea A; Navarra Public Health Institute, CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.
  • Bradbury KE; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Trichopoulou A; Hellenic Health Foundation, Athens, Greece.
  • Bamia C; Hellenic Health Foundation, Athens, Greece.
  • Orfanos P; Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, WHO Collaborating Center for Nutrition and Health, National and Kapodistrian University of Athens, Athens, Greece.
  • Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
  • Pala V; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Vineis P; Italian Institute for Genomic Medicine, Turin, Italy.
  • Bueno-de-Mesquita B; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Ohlsson B; Department of Internal Medicine, Lund University, Skane University Hospital, Malmo, Sweden.
  • Harlid S; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
  • Van Guelpen B; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
  • Skeie G; Department of Community Medicine, Faculty of Health Sciences, University of Tromso, The Arctic University of Norway, Tromso, Norway.
  • Weiderpass E; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Jenab M; Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
  • Murphy N; Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
  • Riboli E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Gunter MJ; Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
  • Aleksandrova KJ; Nutrition, Immunity and Metabolism Start-up Lab, Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrucke, Germany.
  • Tzoulaki I; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Gut ; 68(4): 672-683, 2019 04.
Article em En | MEDLINE | ID: mdl-29615487
ABSTRACT

OBJECTIVE:

To systematically identify and validate published colorectal cancer risk prediction models that do not require invasive testing in two large population-based prospective cohorts.

DESIGN:

Models were identified through an update of a published systematic review and validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) and the UK Biobank. The performance of the models to predict the occurrence of colorectal cancer within 5 or 10 years after study enrolment was assessed by discrimination (C-statistic) and calibration (plots of observed vs predicted probability).

RESULTS:

The systematic review and its update identified 16 models from 8 publications (8 colorectal, 5 colon and 3 rectal). The number of participants included in each model validation ranged from 41 587 to 396 515, and the number of cases ranged from 115 to 1781. Eligible and ineligible participants across the models were largely comparable. Calibration of the models, where assessable, was very good and further improved by recalibration. The C-statistics of the models were largely similar between validation cohorts with the highest values achieved being 0.70 (95% CI 0.68 to 0.72) in the UK Biobank and 0.71 (95% CI 0.67 to 0.74) in EPIC.

CONCLUSION:

Several of these non-invasive models exhibited good calibration and discrimination within both external validation populations and are therefore potentially suitable candidates for the facilitation of risk stratification in population-based colorectal screening programmes. Future work should both evaluate this potential, through modelling and impact studies, and ascertain if further enhancement in their performance can be obtained.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Valor Preditivo dos Testes / Doenças Assintomáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Valor Preditivo dos Testes / Doenças Assintomáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article